chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 10 minutes after vaccine, I suddenly had a very foul taste in my mouth and my face and tongue started tingling. Alerted a nurse there. She gave Benadryl. Waited another 30 minutes. At that stage my throat started feeling tight. Nurse put on finger monitor and blood pressure cuff then gave me a dose of Epi and called 911. Once at hospital ER doctor said I was having an allergic response and gave more Benadryl, famotadine, and prednisone. Then they monitored me for a couple of hours and released me. He prescribed those meds to be continued for 5 days after. I'm itchy an feel very heavy.
Left shoulder pain developed 4/14/14. Swelling to left hand and left fingers developed 4/15/14. Skin to entire left arm was slightly more pink that the right arm. Treatment included ice, Naproxen, Hydrocodone, rest, and gentle stretching exercises.
This 24-year-old female presents with concerns over a spreading rash to her face and left arm that began 2 days after receiving her Smallpox vaccination on 21 May 2004 to her right deltoid.  She indicates the rash by pointing to multiple individual raised white-tan-skin toned papules to her left upper lip.  There is a fine erythematous hue with scattered macularpapules visible to her left cheek, jawline, across her forehead just above the eyebrows and one to top of her left hand.  Dry pink tinged spots to her left forearm were identified as resolved rash site. She complains of facial itching.    The smallpox injection site itched 24-48 hours after inoculation with minimal swelling, no redness or fevers.  Associated symptoms with her Typhoid in the right deltoid toms included slight cervical lymph node swelling for 1-1 ½ days.  It is day 5-6-post smallpox vaccination showing the site with a depressing centered vesicle-pustule with surrounding erythema.  Patient noticed the facial rash begin to her left upper lip as if it were acne breaking out.  She treated with facial scrubs and rubbing alcohol with no relief.  The rash continued to progress over the next few days over her upper lip, cheek, and forehead with increased itching.  Concern over a possible reaction made her consult medical friends and family who suggested she contact the Vaccine Healthcare Center and seek medical care.  She denies any dysphasia, speech difficulty, myalgias, weakness, fatigue, facial pain, tingling, chest pain, breathing problems or persistent lymph node swelling.  She reports receiving her first Anthrax vaccination to the left deltoid and Typhoid in the right deltoid on 18 May 2004 without incident.
Patient up to date on COVID vaccinations who admitted with COVID positive PCR.  Provider d/c note below:  "78 YO male that presented to the ED with c/o SOB and worsening dizziness. Chronic health conditions include  TIA  PAF orthostatic Hypotension T2DM  Hypothyroid  Anxiety  Emphysema. Pt reports that he has been getting very SOB working harder to breathe when up moving around and getting worse dizziness. No cough. His wife reports he has been sleeping more and more through the day and now has his days and nights confused. Today he got up and poured a bowel of cereal and had to take a break before he could finish. She reports that his lips have been blue. He wears the 02 all the time at 2L when resting and has been requesting and increased both at rest and when up moving. Has had major loss of appetite.  He denies chest pain, fever, cold and flu symptoms. Feet and ankles starting swelling two days ago.    In the ED, CTA negative for PE but does show small bilateral pleural effusions and possible pulmonary edema. . BNP 5,001 d dimer 990  EKG is aflutter. Hgb 13.5  Glucose 156. BP has been quite high while in the ED.   (HPI per NP)   Hospital Course: No notes on file patient is a 78yr old male with a history of CAD, Emphysema, Anxiety, Gout, DM, PAfib, Hypothyroidism, Idiopathic hypotension, BPH who presented with SOB and dizziness. He is usually on 2L at home but in past week he has had worsening labored breathing and was found to have covid. He and wife had been vaccinated with mederna and booster. Today he is on highflow oxygen, feels much better today.   Acute on Chronic Hypoxic Respiratory Failure secondary to Covid - Improving clinically on dexamethasone day#8, completed remdesivir and supplemental oxygen. This is in the setting of Emphysema and past smoking history. CT showed Mild to moderate emphysematous changes and possible superimposed interstitial lung disease. He is much improved and now on 4L NC oxygen. He is being discharged to complete dexamethasone (2 more doses for a total of 10 days) and on supplemental oxygen to follow up with PCP.   Idiopathic Orthostatic hypotension - he has had a syncopal episode in the past and more recent episodes of pre-syncope. Improved on midodrine.   Urinary retention with incomplete emptying - difficulty straight cath. Urology consulted - Place Foley catheter, increase tamsulosin 0.8 mg daily, trial of voiding in the next 5-7 days when medically stable, outpatient follow up."
pt recv vax & the same day post vax pt exp diarrhea;24-48 hr post vax pt exp an itchy, bumpy, red raised rash @ side & fever;an ER room or MD visit was required;
Around mid-day the day after vaccination the patient started to experience chills, muscle aches, and flu-like symptoms.  Throughout the day, he developed edema in his legs and feet.   The following day, he noticed a rash on his feet, which resolved after about 24 hours.  He had severe pain through the right side of his body, and some tenderness at the vaccination site.
Friday night, at 04:00, I got a fever and it was low grade until 10:00 pm and it spiked to 103 and it lasted to 01:00 am. I took Tylenol for it. The next morning, at 08:00 am, I woke up to abdominal pain right under my sternum - and it lasted until 08:00 pm that night - it came and went throughout the day but was pretty much over by that night.. I went to Urgent Care. I took Tylenol for the abdominal pain as they did not know the cause of it. I was very tired until Thursday of that next week.
Area on left arm was raised, red, swollen, warm to touch areas, itchy and painful. +cellulitis. Treatment:  Benadryl, Hydrocortisone Cream, 1 %, Keflex  500 MG, 1 capsule, Orally, Twice a day, 10 days. Naproxen Tablet, 500 MG, 1 tablet as needed, Orally, every 12 hrs, 14 days.
All muscles affected, on oxygen, feeding tube still in, sweats a lot, memory affected, difficulty showing, was in wheelchair, still on walker, swallowing problem.
antibodies which was negative; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot/batch number and expiry date unknown), via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on Dec2020. On an unspecified date in 2021, the patient had his/her antibodies checked which was negative. Patient was concerned that the vaccine was not effective as advertised. The outcome of the event was unknown.  Information about lot/batch number has been requested.
chills and sweats; chills and sweats; fatigue; Fever 100.3 day 102.5 worst; inflamed sore swollen arm; everything hurt; inflamed; arm swelling was sick like the flu; flu; feel bad; shoulder pain; This is a spontaneous report from a contactable consumer (patient) in response to non-HCP letter sent in cross-referenced case.  A 45-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9266) via an unspecified route of administration in left arm on 11Feb2021 at 08:15 (at the age of 45-year-old) as single dose for COVID-19 immunization at Clinic. Patient medical history was not reported. Concomitant medications included Niacin started in Dec2021 and was ongoing, lisinopril started in 2011 and was ongoing, venlafaxine started in 2012 and was ongoing, Montelukast started in 2018 and was ongoing all taken for unspecified indications. Patient was not sure about prior vaccinations (within 4 weeks). Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9261) via an unspecified route of administration on 22Jan2021 as single dose for COVID-19 immunization and experienced Headache, tired, slept 8 hours straight and feel bad [1.5 day]. On 11Feb2021 at 15:00, after second dose of vaccination, patient experienced fatigue, sweats, chills, flu, fever 2 days [fever 101 on/off, 100.3], felt bad for 2days, everything hurt, inflamed, sore and swollen arm, arm swelling was sick like the flu and patient was unable to use arm for 1 week. From 12Feb2021-13Feb2021 patient had worst fever of 102.50 and called nurse and received corrective treatment which included Motrin and Tylenol and cold wash cloth. Patient visited Doctor on 25Feb2021 at 14:00 due to shoulder pain, swelling/swollen arm and received steroid shot and after receiving steroid shot arm swelling down and four hours later pain was gone. Outcome of the events were resolved on an unspecified date in Feb2021.  No follow-up attempts are possible. No further information is expected.
Patient says he was feeling well until received vaccine. He complained of feeling heated all over and burning throat that moved to his chest. Patient advised to see MD. Patient was examined by MD and was given MEDROL and benzonatate. Patient says MD did not confirm if this reaction was due to vaccine or not.
48 hrs. after injection, mom called and states child had baseball size area of rash around injection site. Not red or warm.
felt like having COVID again after both doses; Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020, Pneumonia in October 2020 and Blood pressure high (Before both doses of the vaccine, she had high blood pressure). Concomitant products included LOSARTAN for Blood pressure abnormal, ZOLPIDEM TARTRATE (AMBIEN) for Sleeplessness.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40). At the time of the report, SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement: 70/40 (Low) low and sometimes plummets to about 70/40..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include muscle relaxer and pain medication.  Dose adjustment conducted in blood pressure medication.   This case was linked to MOD-2021-220989 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up was received on 8-JUL-2021: contains Non significant information
Alopecia aerata started after 2nd Covid vaccine, no risk factors, no prior history, diagnosed in the office on 1/31
This spontaneous report was received from a patient's wife regarding her husband of unknown age. No medical history was reported. On 13-APR-2013 (reported as 1 week ago last Saturday), the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiry, route, dose not reported). No concomitant medications were reported. On an unknown date in April 2013, the patient experienced redness, swelling and warmth at the injection area that was 3 inch in diameter that lasted a week. The outcome of redness, swelling, warmth at the injection area was reported as recovered approximately on an unknown date in April 2013. Patient's wife also mentioned she received ZOSTAVAX 1 week ago last Saturday and was taking VALTREX every day. Additional information is not expected.
Dyspnea Onset date: 10/1/2023 Subject enrolled in the Janssen study received study medication (Janssen ad26.CoV2. vaccine) on 10/17/2022 HOSPITAL COURSE: 10/1/2023 - 10/4/2023. study patient was recently discharged from the hospital after having fluid removed frim his left lung having been admitted for Dyspnea 9/27/2023 - 9/28/2023. Patient started to have issues breathing when lying flat on 9/30/2028. Patient felt pressure through his chest and abdomen, denies pain currently. Patient has been taking his lasix. Patient's last dialysis was Friday 9/29/2023. He denies any cough or leg swelling. HOSPITAL COURSE Study patient presented back to the ED on 10/1/2023 with worsening dyspnea on exertion. Patient was found to intermittently require 2 L of oxygen on admission. Of note, patient with severe aortic stenosis with associated recurrent pleural effusions. Patient has required numerous thoracentesis in the last 3 months. Given persistent thoracentesis requirement, most recently 09/20/2023, decision to place PleurX drain. PleurX placed 10/4/2023. The patient continued on his home diuretic dose of Lasix 40 mg twice daily. He continued his previous hemodialysis given his end stage renal disease (ESRD). Status post-transplant for which he is on prednisone 5 mg daily. 10/3/2023: Patient not requiring any oxygen prior to discharge. Patient to follow-up with Cardiology for further discussions of potential Transcatheter aortic valve replacement. Home health orders for PleurX management placed. Of note, patient with lingular opacity n CT scan. CT scan recommended to be repeated in 4 weeks per pulmonology team. Patient deemed stable for discharge 10/04/2023 status post Transcatheter aortic valve replacement. Study Principal Investigator has assessed the causality as not study related.
Symptoms started on the 26th as a scratchy throat. By the next morning I had runny nose, nasal congestion and low-grade fever between 99.5 and 100. I had an overall feeling of yuckiness. I was tired and wanted to lay down. This persisted for 2 days. I took prescription strength Ibuprofen that I had from a back injury. I also took saline nasal spray to irrigate my nose and drank a lot of water and stayed in bed. I started to feel better by the 29th. My headache went away mostly. It would come and go. The fever was gone but the nasal congestion persisted. Thru the weekend, symptoms came and went. By that Saturday or Sunday, I was really tired, had a headache that came and went. I took nasal swabs called Zicam to treat the congestion. I went to the emergency room. The doctor tested me for Influenza A and B as well as COVID-19. I was positive for influenza. I was prescribed a nasal spray along with 2 other medications that I did not take. By that point I was past the worst symptoms. Through time most symptoms went away except the nasal congestion. A hot shower and nasal saline spray will help for a period of time and then the congestion returns. I have made a follow up appointment with my doctor. I do consider myself over the flu.
I began losing weight after I received the second vaccine. I lost 16 lbs in seven weeks. I went to my doctor who did bloodwork and advised me that my blood sugar was 516 and that I needed to go to the emergency room immediately. I was admitted to the ICU for three days with an a1c of 12.9 and was ultimately diagnosed with Type 1 Diabetes.
Shaking, chills, fever, severe muscle ache, headache, very painful swollen lymph node in armpit, nausea, apetite loss
11/16/13 c/o severe itching since receiving influenza vaccine originally to (L) arm but spreading to rest of body. No rash noted.
Within 3 hours - Fatigue, injection site pain Within 6 hours - Fatigue, injection site pain, chills Within 24 hours - Fatigue, increased injection site pain Within 4 days - injection site redness
p/leaving clinic following vax pt began crying, shaking, turning blue; no loss of consciousness; no hx allergies; t101.2; pt seen by MD alert, terrified, screaming; difficulty to examine; no airway obstruction;
significantly worsened anxiety with panic attacks.  Issues have been well controlled until night after vaccine.  Hasn't felt well since.
A few minutes after receiving the vaccine, patient complained of dizziness and sat down.  Within just a couple of minutes she was losing consciousness.  911 was called and EMT came within 5-8 minutes and patient was on floor.  EMT assessed patient and transported to local hospital (Medical Center).  Patient was seen and discharged and the physician at the hospital did not feel the seizure was a result of the vaccination but her medical condition and history of seizures.
Possible generalized tonic-clonic seizure lasting <5 minutes on 10/10/08 early am.
No additional AE reported.; a patient received her first dose of GARDASIL 9 in 2013 at age 13 years old and her second dose in 2019 at age 17 years old; This spontaneous report was received from a physician and refers to a female patient of unknown age. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided.  On an unknown date in 2013 (at age 13 years old), the patient was vaccinated with her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 milliliter (injection site, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date in 2019 (at age 17 years old), the patient was vaccinated with her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 milliliter (injection site, route of administration, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration).  The reported did not want to provide any patient information. No additional adverse events (AE) were reported.
This spontaneous case was reported by a consumer and describes the occurrence of ANIMAL SCRATCH (scratched by a cat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANIMAL SCRATCH (scratched by a cat). At the time of the report, ANIMAL SCRATCH (scratched by a cat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant drugs were reported. Treatment drugs includes IV antibiotics and oral antibiotics for scratches by cat patient was suppose to receive 2nd dose vaccine on 8feb2021 but didn't receive it since had question whether can get vaccine while on antibiotics .
lips swollen; throat has some tightness; chest has some tightness; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips swollen), THROAT TIGHTNESS (throat has some tightness) and CHEST DISCOMFORT (chest has some tightness) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced LIP SWELLING (lips swollen), THROAT TIGHTNESS (throat has some tightness) and CHEST DISCOMFORT (chest has some tightness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LIP SWELLING (lips swollen), THROAT TIGHTNESS (throat has some tightness) and CHEST DISCOMFORT (chest has some tightness) outcome was unknown.            No concomitant medication was provided.
shaking all over; breathing really hard; nauseated; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Alzheimer's disease. Concomitant products included CLOPIDOGREL, GALANTAMINE and ROSUVASTATIN.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves). On 28-Feb-2021, TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.    Reporter did not allow further contact
Patient describes feeling "very achy" for 3 days following shot. Able to go out to dinner, per wife and walk around. Per the patient, it was very uncomfortable to sleep on his back. Afebrile. TYLENOL taken and ineffective.
Patient did not have any redness but terrible pain in her arm starting day of vaccine. Post 3 days today (9-14-19) and is just starting to be able to move it.  Could not move at all the first day, could not lay on it and took around the clock tylenol.
Headache; Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 66 year-old female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Lot number: EN6202) at the age of 66 years as dose 1, single and administration date 19Mar2021 (Lot number: ER2613) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 27Feb2021, outcome "recovered" (28Feb2021), described as "Headache"; FATIGUE (non-serious) with onset 27Feb2021, outcome "recovered" (28Feb2021), described as "Tiredness". Additional Information: Age at second dose vaccination was 66-year-old. After second dose, the patient experienced headache and tiredness on 20Mar2021 with outcome "recovered" on 21Mar2021.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101781711 same patient, same reporter, different dose, similar event